Kong XY, Lauritzen KH, Dahl TB, Holm S, Olsen MB, Skjelland M, Nielsen C, Michelsen AE, Ueland T, Aukrust P, Halvorsen B, Sandanger Ø (2024) CD38 deficient mice are not protected from atherosclerosis Biochem Biophys Res Commun, 705, 149734 (in press) DOI 10.1016/j.bbrc.2024.149734, PubMed 38430607 Jørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B (2024) Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency Sci Rep, 14 (1), 3704 DOI 10.1038/s41598-024-54117-6, PubMed 38355714 Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024) Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity Genome Med, 16 (1), 27 DOI 10.1186/s13073-024-01296-6, PubMed 38331891 More publications